金龙胶囊防治肝癌的临床与基础研究进展
基础研究显示JLC可抑制体内外肿瘤生长并调节免疫,可能机制包括抑制肿瘤细胞增殖、促进凋亡、抑制血管生成及调节细胞免疫;临床与现代化治疗联用有助于防治复发转移、延长生存、提高客观缓解率、减轻胃肠道不良反应、改善生存质量及调节免疫功能。
要点
- 金龙胶囊联合现代治疗可助防肝癌复发转移、延长生存并提高客观缓解率。
- JLC可减轻胃肠道不良反应、改善生存质量并调节机体免疫功能。
- 基础机制涉及抑制增殖、促进凋亡、抑制血管生成与调节细胞免疫。
核心结论
- 金龙胶囊联合现代治疗手段有助于防治肝癌复发转移、延长患者生存并提高肿瘤客观缓解率。
- JLC可减轻胃肠道不良反应、改善生存质量、调节免疫功能并提高用药安全性。
主要发现
- 基础研究显示JLC可抑制体内和体外肿瘤生长并发挥免疫调节作用。
- JLC的可能机制包括抑制肿瘤细胞增殖、促进肿瘤细胞凋亡、抑制血管生成及调节细胞免疫。
临床怎么用
- 临床可将JLC与现代治疗方法联合用于肝癌的防治,以助控制复发转移并改善生存质量。
- 使用JLC时需关注其减轻胃肠道不良反应及调节免疫功能的潜在获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Primary liver cancer, characterized by an insidious onset, rapid progression, high degree of heterogeneity, difficulties in treatment, and a short survival time, poses a significant threat to human health. Jinlong capsule (JLC), an original drug developed in China, is a Chinese patent medicine used to treat liver cancer. Research has demonstrated the antitumor effects of JLC, attributed to its unique preparation process. When used in combination with modern treatment methods, JLC helps in preventing and treating liver cancer recurrence and metastasis, prolonging patient survival, increasing the tumor objective response rate, alleviating gastrointestinal adverse reactions, enhancing survival quality, regulating immune functions of the body, relieving clinical symptoms, and improving patient safety. This study provides a review of clinical and basic research results on JLC. METHODS: We performed literature searches in the Cochrane Library, Embase, PubMed, OVID Scopus, China Biology Medicine, China National Knowledge Infrastructure, VIP, and Wanfang databases for articles published from database inception to December 2023. RESULTS: Basic research has revealed that the effects of JLC include the inhibition of tumor growth in vivo and in vitro and immune modulation. The possible mechanisms include inhibiting tumor cell proliferation, promoting tumor cell apoptosis, inhibiting angiogenesis, and modulating cellular immunity. DISCUSSION: By attuning to the complex biological characteristics of liver cancer, harnessing the unique and unconventional advantages of traditional Chinese medicine, and focusing on clinical needs, we propose directions for future evidence-based research on using JLC in the prevention and treatment of liver cancer. This will contribute to the development of precision synergistic strategies that combine traditional Chinese medicine and modern medicine treatment methods.
引用
- Lv L, Ren S, Zhang Z, et al. Clinical and basic research advances on Jinlong capsule for the prevention and treatment of liver cancer. Front Pharmacol. 2025. PMID: 40552154. doi:10.3389/fphar.2025.1522945
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。